Circulating MicroRNAs and Aerobic Fitness - The HUNT-Study

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Bye, Anja ^a   Røsjø, Helge ^b   Aspenes, Stian T ^a   Condorelli, Gianluigi ^c,d   Omland, Torbjørn ^b   Wisløff, Ulrik ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^c Milan Unit   (Italy)

^d HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA 21; MICRORNA 210; MICRORNA 222;

ADULT; AEROBIC FITNESS; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; GENE IDENTIFICATION; GENE TARGETING; HEALTH STATUS; HEART MUSCLE OXYGEN CONSUMPTION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PHYSICAL ACTIVITY; RISK FACTOR; SIGNAL TRANSDUCTION;

ADULT; COHORT STUDIES; EXERCISE; FEMALE; HUMANS; MALE; MICRORNAS; OXYGEN CONSUMPTION; PHYSICAL FITNESS;

EID: 84874578201     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057496     Document Type: Article

References (50)

1. LaMonte MJ, Barlow CE, Jurca R, Kampert JB, Church TS, et al. (2005) Cardiorespiratory fitness is inversely associated with the incidence of metabolic syndrome: a prospective study of men and women. Circulation 112: 505-512.
2. Farrell SW, Cheng YJ, Blair SN, (2004) Prevalence of the metabolic syndrome across cardiorespiratory fitness levels in women. Obes Res 12: 824-830.
3. Kavanagh T, Mertens DJ, Hamm LF, Beyene J, Kennedy J, et al. (2002) Prediction of long-term prognosis in 12 169 men referred for cardiac rehabilitation. Circulation 106: 666-671.
4. Myers J, Prakash M, Froelicher V, Do D, Partington S, et al. (2002) Exercise Capacity and Mortality among Men Referred for Exercise Testing. New England Journal of Medicine 346: 793-801.
5. Booth FW, Chakravarthy MV, Gordon SE, Spangenburg EE, (2002) Waging war on physical inactivity: using modern molecular ammunition against an ancient enemy. J Appl Physiol 93: 3-30.
6. Cortez MA, Calin GA, (2009) MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opin Biol Ther 9: 703-711.
7. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
8. Thum T, Catalucci D, Bauersachs J, (2008) MicroRNAs: novel regulators in cardiac development and disease. Cardiovasc Res 79: 562-570.
9. Care A, Catalucci D, Felicetti F, Bonci D, Addario A, et al. (2007) MicroRNA-133 controls cardiac hypertrophy. Nat Med 13: 613-618.
10. Latronico MV, Catalucci D, Condorelli G, (2007) Emerging role of microRNAs in cardiovascular biology. Circ Res 101: 1225-1236.
11. Ai J, Zhang R, Li Y, Pu J, Lu Y, et al. (2010) Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem Biophys Res Commun 391: 73-77.
12. Tijsen AJ, Creemers EE, Moerland PD, de Windt LJ, van der Wal AC, et al. (2010) MiR423-5p as a circulating biomarker for heart failure. Circ Res 106: 1035-1039.
13. Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, et al. (2010) Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 31: 659-666.
14. Ji X, Takahashi R, Hiura Y, Hirokawa G, Fukushima Y, et al. (2009) Plasma miR-208 as a biomarker of myocardial injury. Clin Chem 55: 1944-1949.
15. Corsten MF, Dennert R, Jochems S, Kuznetsova T, Devaux Y, et al. (2010) Circulating MicroRNA-208b and MicroRNA-499 Reflect Myocardial Damage in Cardiovascular Disease. Circ Cardiovasc Genet 3: 499-506.
16. Baggish AL, Hale A, Weiner RB, Lewis GD, Systrom D, et al. (2011) Dynamic regulation of circulating microRNA during acute exhaustive exercise and sustained aerobic exercise training. J Physiol 589: 3983-3994.
17. Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y, et al. (2010) Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 285: 17442-17452.
18. Aspenes ST, Nauman J, Nilsen TI, Vatten L, Wisloff U, (2011) Physical Activity as a Long Term Predictor of Peak Oxygen Uptake: The HUNT-Study. Med Sci Sports Exerc 43: 1675-1679.
19. Rognmo Ø, Hetland E, Helgerud J, Hoff J, Slørdahl SA, (2004) High intensity aerobic interval exercise is superior to moderate intensity exercise for increasing aerobic capacity in patients with coronary artery disease. Eur J Cardiovasc Prev Rehabil 11: 216-222.
20. Meyer T, Davison RC, Kindermann W, (2005) Ambulatory gas exchange measurements-current status and future options. Int J Sports Med 26Suppl 1: S19-27.
21. Shephard RJ (2000) Maximal Oxygen Uptake. In: Shephard RJ, Åstrand PO, editors. Endurance in Sport. Second ed. Cornwall: Blackwell Science. 301-310.
22. Kurtze N, Rangul V, Hustvedt BE, Flanders WD, (2008) Reliability and validity of self-reported physical activity in the Nord-Trøndelag Health Study: HUNT 1. Scand J Public Health 36: 52-61.
23. Lindstrom J, Tuomilehto J, (2003) The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 26: 725-731.
24. Selmer R, Lindman AS, Tverdal A, Pedersen JI, Njolstad I, et al. (2008) [Model for estimation of cardiovascular risk in Norway]. Tidsskr Nor Laegeforen 128: 286-290.
25. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, et al. (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97: 1837-1847.
26. Chang KH, Mestdagh P, Vandesompele J, Kerin MJ, Miller N, (2010) MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer. BMC Cancer 10: 173.
27. Papadopoulos GL, Alexiou P, Maragkakis M, Reczko M, Hatzigeorgiou AG, (2009) DIANA-mirPath: Integrating human and mouse microRNAs in pathways. Bioinformatics 25: 1991-1993.
28. Huang X, Le QT, Giaccia AJ, (2010) MiR-210-micromanager of the hypoxia pathway. Trends Mol Med 16: 230-237.
29. Ivan M, Harris AL, Martelli F, Kulshreshtha R, (2008) Hypoxia response and microRNAs: no longer two separate worlds. J Cell Mol Med 12: 1426-1431.
30. Fasanaro P, D'Alessandra Y, Di Stefano V, Melchionna R, Romani S, et al. (2008) MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol Chem 283: 15878-15883.
31. Kulshreshtha R, Ferracin M, Wojcik SE, Garzon R, Alder H, et al. (2007) A microRNA signature of hypoxia. Mol Cell Biol 27: 1859-1867.
32. Camps C, Buffa FM, Colella S, Moore J, Sotiriou C, et al. (2008) hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin Cancer Res 14: 1340-1348.
33. Chan SY, Zhang YY, Hemann C, Mahoney CE, Zweier JL, et al. (2009) MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2. Cell Metab 10: 273-284.
34. Semenza GL, (2010) Vascular responses to hypoxia and ischemia. Arterioscler Thromb Vasc Biol 30: 648-652.
35. Li T, Cao H, Zhuang J, Wan J, Guan M, et al. (2011) Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans. Clin Chim Acta 412: 66-70.
36. Lorenzen JM, Kielstein JT, Hafer C, Gupta SK, Kumpers P, et al. (2011) Circulating miR-210 predicts survival in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol 6: 1540-1546.
37. van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, et al. (2006) A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A 103: 18255-18260.
38. Tatsuguchi M, Seok HY, Callis TE, Thomson JM, Chen JF, et al. (2007) Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J Mol Cell Cardiol 42: 1137-1141.
39. Sayed D, Hong C, Chen IY, Lypowy J, Abdellatif M, (2007) MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res 100: 416-424.
40. Cheng Y, Liu X, Zhang S, Lin Y, Yang J, et al. (2009) MicroRNA-21 protects against the H(2)O(2)-induced injury on cardiac myocytes via its target gene PDCD4. J Mol Cell Cardiol 47: 5-14.
41. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, et al. (2008) MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456: 980-984.
42. Weber M, Baker MB, Moore JP, Searles CD, (2010) MiR-21 is induced in endothelial cells by shear stress and modulates apoptosis and eNOS activity. Biochem Biophys Res Commun 393: 643-648.
43. Roy S, Sen CK, (2011) MiRNA in innate immune responses: novel players in wound inflammation. Physiol Genomics 43: 557-565.
44. Poliseno L, Tuccoli A, Mariani L, Evangelista M, Citti L, et al. (2006) MicroRNAs modulate the angiogenic properties of HUVECs. Blood 108: 3068-3071.
45. Liu X, Cheng Y, Zhang S, Lin Y, Yang J, et al. (2009) A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res 104: 476-487.
46. Greco S, Fasanaro P, Castelvecchio S, D'Alessandra Y, Arcelli D, et al. (2012) MicroRNA Dysregulation in Diabetic Ischemic Heart Failure Patients. Diabetes 61: 1633-1641.
47. Thum T, Galuppo P, Wolf C, Fiedler J, Kneitz S, et al. (2007) MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 116: 258-267.
48. Stokke O (1982) Clinical chemical changes in physical activity. Scand J Soc Med Suppl 29: 93-101.
49. Raitoharju E, Lyytikainen LP, Levula M, Oksala N, Mennander A, et al. (2011) miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study. Atherosclerosis 219: 211-217.
50. Bostjancic E, Zidar N, Glavac D, (2009) MicroRNA microarray expression profiling in human myocardial infarction. Dis Markers 27: 255-268.